From AI and biotechnology to advanced diagnostics, robotics and digital health, India is building a healthcare technology ecosystem that could transform patient care and strengthen its position as a global healthcare destination.
By Shinto Kallattu
Artificial intelligence is moving into diagnostics and clinical decision support. Digital platforms are connecting patients and doctors across geographical boundaries. Biotechnology and genomics are opening new possibilities in personalised medicine, while advanced medical devices, robotics and remote monitoring are changing how healthcare is delivered.
India enters this transformation with considerable strengths: a large and diverse patient population, globally recognised pharmaceutical capabilities, a strong technology sector, highly skilled doctors and scientists, an expanding startup ecosystem and a growing network of advanced hospitals.
The opportunity is to bring these strengths together.
AI Moving Closer to Healthcare
Artificial intelligence is emerging as one of the most important technologies shaping the future of medicine.
Its applications are expanding across medical imaging, disease screening, clinical decision support, hospital operations, drug discovery, genomics and remote healthcare.
For India, the scale of the healthcare system makes AI particularly significant. Properly validated AI tools could help doctors analyse large volumes of information, support screening and extend specialist capabilities to areas where access to experts is more limited.
The Government of India has already established important foundations. In February 2026, it launched the Strategy for Artificial Intelligence in Healthcare for India (SAHI) and the Benchmarking Open Data Platform for Health AI (BODH) to encourage safe, evidence-based and inclusive applications of AI in healthcare.
IndiaAI and the Indian Council of Medical Research have also partnered to develop a nationally coherent and interoperable AI ecosystem for healthcare.
International developments demonstrate the possibilities. In China, widely used platforms such as WeChat and Alipay have become gateways to healthcare services, including appointments and telemedicine, while AI-enabled doctor avatars are also being explored.
India’s opportunity is to build a digital healthcare experience suited to its own population and healthcare infrastructure.
The Digital Health Advantage
India’s health-tech journey did not begin with generative AI.
The country has already developed substantial digital health capabilities through telemedicine, online consultations and the Ayushman Bharat Digital Mission, which is creating infrastructure to connect different participants across the healthcare ecosystem.
For a country as geographically diverse as India, digital connectivity can make a significant difference.
Specialists in metropolitan hospitals can potentially support patients in smaller cities. Remote monitoring can extend care beyond hospital walls. Digital records and virtual follow-ups can improve continuity of care.
This has particular relevance for medical tourism.
An international patient’s healthcare journey can increasingly begin with a digital consultation, continue through treatment in India and conclude with remote follow-up after returning home.
Technology can therefore strengthen India’s medical tourism proposition beyond the hospital itself.
Biotechnology: The Next Growth Frontier
India’s pharmaceutical industry has already established a powerful global presence in generic medicines, vaccines and pharmaceutical manufacturing.
The next opportunity is to expand further into innovative drug discovery, biologics, biosimilars, precision medicine and advanced therapeutics.
Developments in China demonstrate the potential of this transition. Chinese biotechnology companies have developed drug candidates that have attracted licensing interest from major global pharmaceutical companies, reflecting the growing importance of Asian research in international drug development.
India is strengthening its own capabilities in this area.
The ₹5,000-crore Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme supports research in areas including new chemical entities, new biological entities, complex generics and biosimilars, precision medicine, medical devices and orphan drugs.
The Department of Biotechnology is also promoting the convergence of AI and life sciences, including initiatives around genome sequencing, genomics diagnostics, biomolecular design and synthetic biology.
The convergence of AI, biotechnology and clinical research could become one of India’s most important healthcare opportunities.
Smarter Medical Devices
Healthcare innovation is not limited to software.
Imaging systems, wearables, remote monitoring devices, surgical technologies and robotic platforms are becoming increasingly intelligent and connected.
China’s advances in specialised ultrasound, surgical robotics and brain-computer interfaces illustrate how quickly medical technology is moving towards the convergence of software, electronics, engineering and clinical medicine. A Rest of World report noted that China’s NEO system from Neuracle received approval in March 2026, describing it as the world’s first commercial approval of an invasive brain-computer-interface medical device.
India has significant potential in this field.
Its engineering talent, software expertise, clinical capabilities and expanding medical-device manufacturing base provide a strong foundation for developing indigenous MedTech. The Department of Pharmaceuticals has identified AI-enabled MedTech, including diagnostics and clinical decision-support technologies, as an important opportunity for India.
Hospitals as Innovation Hubs
India’s hospitals can play a crucial role in the next stage of health-tech development.
Hospitals understand real-world clinical challenges. Doctors know where existing technologies fall short, while engineers and startups bring technological and product-development capabilities.
Closer collaboration among hospitals, universities, startups, researchers and industry can help transform clinical problems into practical innovations.
This could allow hospitals to become not only users of healthcare technology, but also centres for co-development, testing and clinical validation.
India’s large network of hospitals and medical institutions gives it a significant platform for this approach.
A New Dimension for Medical Tourism
The healthcare technology revolution could also reshape India’s position in global medical tourism.
India is already known for experienced doctors, advanced hospitals, complex treatment capabilities and comparatively affordable care.
Technology can add another dimension.
An international patient could receive a preliminary digital consultation before travelling, share medical records electronically, undergo advanced diagnostics on arrival, access robotic or minimally invasive treatment where appropriate, and continue follow-up remotely after returning home.
The medical tourism journey could increasingly become a digital-to-clinical-to-digital continuum.
This would allow India’s healthcare technology capabilities to complement its existing strengths in clinical care and affordability.
Creating Technology for the World
India’s opportunity extends beyond adopting technologies developed elsewhere.
Technologies designed to work effectively in India’s diverse healthcare environment—affordable diagnostics, portable medical devices, AI-supported screening, remote-care platforms and digital health solutions—could also find applications across Asia, Africa, the Middle East and other emerging markets.
This creates an opportunity for India to expand its healthcare exports beyond medicines and treatment.
The country could increasingly offer the world:|
Medicines + Medical Devices + Digital Health + Clinical Expertise + Healthcare Technology.
Building India’s Own Innovation Ecosystem
India does not need to replicate another country’s healthcare model. It can build on its own strengths.
Its emerging healthcare innovation ecosystem brings together:
• Pharmaceutical and biotechnology capabilities
• AI and software expertise
• Digital public infrastructure
• World-class hospitals
• Medical and scientific talent
• Growing MedTech manufacturing
• A vibrant startup ecosystem
• Increasing investment in research and innovation
The Research, Development and Innovation scheme, launched in 2025 with a ₹1 lakh crore outlay over six years, includes strategic areas such as AI, biotechnology, biomanufacturing, pharmaceuticals and medical devices.
These initiatives are creating an increasingly supportive environment for healthcare innovation.
The Next Chapter
The global healthcare landscape is changing rapidly as technology, medicine and science converge.
India is well positioned to participate in this transformation—not simply as a consumer of healthcare technology, but increasingly as a creator and exporter of healthcare solutions.
AI can support earlier diagnosis. Biotechnology can enable new therapies. Genomics can advance personalised medicine. Robotics can expand minimally invasive treatment. Digital health can connect patients and specialists. Smart medical devices can extend monitoring beyond hospitals.
The real opportunity lies in connecting these developments into one ecosystem.
For medical tourism, the implications are significant. India’s future proposition to international patients could combine clinical excellence, advanced technology, affordability and a digitally connected patient journey.
India’s healthcare story has long been about treating patients and producing medicines for the world.
The next chapter could be about something even broader: developing the technologies, therapies and healthcare solutions that help shape the future of medicine globally.